AutoDELFIA® immunoassay system for prenatal screening is supported by the widest available range of prenatal analytes available on any platform. Reliable and easy to use AutoDELFIA instrument offers high quality results both for aneuploidy and pre-eclampsia risk assessment during pregnancy.
This version of the 1420 VICTOR™ EnLite™ fluorometer is supplied with a stacker to allow semi-automatic operation. The instrument may also be used without the stacker, and plates may then be loaded manually.
TQD (Tandem Quadrupole Detector) represents the latest MSMS instrumentation for newborn screening applications. TQD combines the known robust features from the Quattro micro MSMS instrument with further improved scan speed and sensitivity.
TriNEST incubator shaker is a high-quality solution for all well plate applications, where accurate and fast temperature and/or shaking control are needed. TriNEST is a first-class choice for e.g. primer extension and DNA hybridization. For rapid cooling, a cooling block is now also available.
The VICTOR2™ D fluorometer is designed for all PerkinElmer diagnostic and screening assays based on either time-resolved fluorescence or prompt fluorescence. VICTOR2 D includes MultiCalc software for assay evaluation and quality control.
DELFIA® Xpress random access platform for prenatal screening. Confidence in your results, total flexibility of a random access system, full range of 1st and 2nd trimester kits for prenatal and pre-eclampsia screening
The DELFIA® Xpress PlGF 1-2-3 kit is for the quantitative determination of Placental Growth Factor (PlGF) in maternal serum. The kit is used as an aid in screening pregnant women for pre-eclampsia in all pregnancy trimesters, and for screening for the risk of Down’s syndrome in the first trimester of pregnancy.
The NeoBase™ 2 Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase™ 2 Non-derivatized MSMS kit (3044-0010) to extract target analytes from blood samples dried on filter paper and to carry target analytes to the MSMS system.
The high performance DELFIA/AutoDELFIA PAPP-A/ Free hCGß Dual DBS kit is intended for the quantitative determination of human PAPP-A (pregnancy associated plasma protein A) and Free hCGß (the free beta subunit of human chorionic gonadotropin) in maternal blood dried on filter paper. The kit is suitable for use with either the PerkinElmer AutoDELFIA automatic immunoassay system or the manual DELFIA system.
The MSMS Vitamin D Kit is an in vitro diagnostic high performance liquid chromatography tandem mass spectrometry (HPLC-MSMS) reagent kit, intended for the quantitative determination of 25-hydroxy-vitamin D2 and 25-hydroxy-vitamin D3 in human serum samples.
The NeoBase MSMS kit is intended for the quantitative determination of up to 11 clinically significant amino acids and 31 clinically significant acylcarnitines, detecting more than 30 different metabolic diseases from a single dried blood spot sample using the MS/MS tandem mass spectrometer.
The Haemoglobin FASC control is intended to be used as a position marker monitor for haemoglobin variant analysis methods and to assess assay reproducibility in the following assay types: ion exchange HPLC, capillary electrophoresis, cellulose acetate and agar/agarose gel electrophoresis and iso-electric focusing.
This kit is intended for the quantitative determination of human 17-OH-progesterone in blood specimens dried on filter paper as an aid in screening newborns for congenital adrenal hyperplasia (CAH) using the 1235 AutoDELFIA® automatic immunoassay system.
The NeoBase Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase Non-derivatized MSMS Kit and the NeoBase Succinylacetone Solution. The product includes NeoBase Flow Solvent and NeoBase Extraction Solution.
The NeoLSD™ MSMS Kit is intended for the quantitative measurement of the activity of the enzymes acid-β-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid α glucosidase (GAA), β galactocerebrosidase (GALC), α-galactosidase A (GLA) and α-L-iduronidase (IDUA) in dried blood spots (DBS) from newborn babies.
The GSP® is a high throughput batch analyzer intended for quantitative or qualitative measurement of neonatal screening samples on 96-well microplates. The instrument is fully automated, performing every stage of an assay from retrieval of the sample plate from the stacker to measurement and reporting of results.
PerkinElmer PlGF Controls have been prepared with human pregnancy serum. The product is intended for use as an assayed quality control serum to monitor precision of laboratory measurement procedures for the DELFIA PlGF assays run on DELFIA Xpress, AutoDELFIA or manual DELFIA platforms.
Neonatal Galactose Transferase (GALT) kits are intended for the semi-quantitative determination of galactose-1-phosphate uridyltransferase (GALT) activity in blood specimens collected onto filter paper, in screening newborns for galactosemia.
The NeoGram Derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoGram Amino Acids and Acylcarnitines (AAAC) Tandem Mass Spectrometry Kit. The product includes NeoGram AAAC Flow Solvent, NeoGram AAAC Extraction Solution, NeoGram AAAC Reconstitution Solution and 3.0 N HCL in n-butanol.
Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage.
This kit is intended for the quantitative determination of human thyroxine (T4) in bloodspecimens dried on filter paper as an aid in screening newborns for congenital (neonatal) hypothyroidism using the 1235 AutoDELFIA® automatic immunoassay system.
Neonatal G6PD kits are intended for the semi-quantitative determination of glucose-6-phosphate dehydrogenase (G6PD) concentrations in blood specimens collected onto filter paper, as an aid in screening newborns for G6PD deficiency.
Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.
The DELFIA® and AutoDELFIA™ hAFP/Free hCGß Dual kits are for the simultaneous quantitative determination of human Alpha-fetoprotein (hAFP) and the free beta subunit of human Chorionic Gonadotrophin (Free hCGß) in maternal serum.
The DELFIA® Xpress PAPP-A kit is intended for the quantitative determination of PAPP-A (Pregnancy Associated Plasma Protein A) in maternal serum. The kit is used for screening for the risk of Down’s syndrome and as an aid in screening pregnant women for pre-eclampsia in the first trimester of pregnancy.
The DELFIA®/AutoDELFIA® PlGF 1-2-3 kit quickly and accurately detects levels of Placental Growth Factor (PlGF) in maternal serum. The kit may be used with either the AutoDELFIA automated immunoassay system or the manual DELFIA system.
Wallac DELFIA® and AutoDELFIA™ uE3 Kits are for the quantitative determination of human unconjugated Estriol (uE3) in serum. Maternal Estriol levels have been used to monitor fetal status during pregnancy. Decreased levels of uE3 can be seen in pregnancies affected with Down´s syndrome in the second trimester of the pregnancy.
The DELFIA®/AutoDELFIA® PlGF kit quickly and accurately detects levels of Placental Growth Factor (PlGF) in maternal serum (free PlGF, isoform 1). The kit may be used with either the AutoDELFIA automated immunoassay system or the manual DELFIA system.
Neonatal Biotinidase kit is intended for the semi-quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency.
Products and Services